Elsa G. Barbacci
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Medicine top 5%
- Co-authors
- James D. MoyerKenneth K. IwataLeslie R. PustilnikVincent A. PollackJohn A. DavisMichael J. MorinLee D. ArnoldDeborah A. Baker
- Topics
- HER2/EGFR in Cancer Research (7 papers)Glycosylation and Glycoproteins Research (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologyBiochemical and Biophysical Research Communications
- Partner nations
- United StatesCanada
In The Last Decade
Elsa G. Barbacci
8 papers receiving 731 citations
Peers
Comparison fields: 5 of 70
- Oncology 396
- Molecular Biology 376
- Pulmonary and Respiratory Medicine 215
- Radiology, Nuclear Medicine and Imaging 120
- Molecular Medicine 98
Countries citing papers authored by Elsa G. Barbacci
This map shows the geographic impact of Elsa G. Barbacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa G. Barbacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa G. Barbacci more than expected).
Fields of papers citing papers by Elsa G. Barbacci
This network shows the impact of papers produced by Elsa G. Barbacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa G. Barbacci. The network helps show where Elsa G. Barbacci may publish in the future.
Co-authorship network of co-authors of Elsa G. Barbacci
This figure shows the co-authorship network connecting the top 25 collaborators of Elsa G. Barbacci. A scholar is included among the top collaborators of Elsa G. Barbacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa G. Barbacci. Elsa G. Barbacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 125 | |
| 2 | 3 | |
| 3 | The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells. | 40 |
| 4 | 369 | |
| 5 | 79 | |
| 6 | 110 | |
| 7 | 1 | |
| 8 | 40 |
About Elsa G. Barbacci
Elsa G. Barbacci is a scholar working on Toxicology, Oncology and Molecular Medicine, having authored 8 papers that have together received 767 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Molecular Medicine (98 citations), Oncology (396 citations) and Endocrinology (55 citations). Elsa G. Barbacci has collaborated with scholars based in United States and Canada. Frequent co-authors include James D. Moyer, Kenneth K. Iwata, Leslie R. Pustilnik, Vincent A. Pollack, John A. Davis, Michael J. Morin, Lee D. Arnold, Deborah A. Baker, Teresa A. Smolarek and Konstantinos Tsaparikos. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.